EU đặt mua 220.000 liệu trình điều trị COVID-19 của GlaxoSmithKline

Ngày 28/7, Liên minh châu Âu (EU) cho biết đã ký một thỏa thuận với công ty dược phẩm GlaxoSmithKline của Anh về việc cung cấp lên đến 220.000 liệu trình thuốc Sotrovimab điều trị bệnh nhân COVID-19 bằng kháng thể đơn dòng mà hãng này đang phát triển. GlaxoSmithKline cùng ngày cũng đã xác nhận thỏa thuận này.

P8OqPinhurVpMuG7m+G7m1ko4buV4buc4bq/4budaeG6pyg64bqm4buiKeG6pcOh4budKcOt4bujMil7ezwkPDw8KWnhur9l4bujKeG7ncah4buHw6zDqinhuqXhur/EkeG7oynhu53GoeG7gynhurThu4rhu6bhur7Dgi0+MSnhurVxMinhurxpMsaw4buL4buaw63hur/hu53Dqkhp4bq/w6zhuqc/L8OqPjo/4buVKeG6tWky4bub4bubWSjhu5XDiuG6pzLDoig6w4zhur004bupKXswLyA9KUnhur9jw6wpw63hur/DrMOqKeG6tcOq4bqj4bujKeG6ouG7oykq4bqm4buiJinhurXDquG7iynhurPhur9k4budKeG6pTcpaOG7qynDrcOz4budKeG7ncOqazIp4budw6rhu6Phuq/DrCnhu6fDteG6vynhurVtw6zhur0p4bud4bupKcOic+G7keG6tSnhu5XDquG6scOtKeG6vGkyxrDhu4vhu5rDreG6v+G7ncOqSGnhur/DrOG6pynhurVxMil3w6zDqinhu6fEkSnhu6fhur9l4bq1KeG6teG7o8Os4bq9KeG6tcOj4buVKWljw6wp4bqlZMOsKXt7PCQ8PDwpaeG6v2Xhu6Mp4budxqHhu4fDrMOqKeG7ncOq4bujbuG6tSnhu5rhu4vhu53GoeG7i+G7p+G6v8OtMuG6synhuqXhur/EkeG7oynhu53GoeG7gynhurNlw6zDqinDrMOq4bqjw6wp4bq04buK4bum4bq+w4ItPjEp4bqzYcOs4bq9KWjDqjPDrOG6vSnhu53DqsOpKeG6peG7j8OsKcOixKnDrOG6vSnDrTQpw6o3w6zhur0pw6w04bupKeG6pTLDrOG6vSnhu5XDqjPhu50p4budxqHhur/DqcOsJCnhurxpMsaw4buL4buaw63hur/hu53Dqkhp4bq/w6zhuqcp4bq14buhw6zhur0pw6zhur004bupKeG6tXLDrOG6vSnhuqU3KcawM+G6tSnDrMOq4bqvw6wp4budw6prMinhu53DquG7o+G6r8OsKcOsNOG7qSQ/L+G7lTo/4buVKeG6tWky4bub4bubWSjhu5XhurLhu4vDouG7qSg6P+G6v8Ot4bq9KeG6tWky4bub4bubWSjhurXDreG7my3hu5XDquG7i+G7neG7iygp4bud4bq/4budaeG6p1ko4bqm4buiKeG6pcOh4budKcOt4bujMil7ezwkPDw8KWnhur9l4bujKeG7ncah4buHw6zDqinhuqXhur/EkeG7oynhu53GoeG7gynhurThu4rhu6bhur7Dgi0+MSnhurVxMinhurxpMsaw4buL4buaw63hur/hu53Dqkhp4bq/w6zhuqcpw6rhu4fDrMOqKTbDrMOqKT4oKeG7m8ah4bq1WSgvL+G6tSThurMy4buL4budw6oyw6zDqsOq4buLMiThu6fDrC/hur/DreG6vS/DouG6p+G7m2jhu53hu4vhu5Uvw6zhuqfFqeG7my97Pn08Lz4gIMOiWzwwWyBdW+G7nTF7XWk+JMWp4bqn4bqz4buVKCkyaeG7nVko4bqm4buiKeG6pcOh4budKcOt4bujMil7ezwkPDw8KWnhur9l4bujKeG7ncah4buHw6zDqinhuqXhur/EkeG7oynhu53GoeG7gynhurThu4rhu6bhur7Dgi0+MSnhurVxMinhurxpMsaw4buL4buaw63hur/hu53Dqkhp4bq/w6zhuqcoKcOiMuG7nTIt4buVw6rhu4vhu53hu4st4buLxqHhur/hur3hur/DrDJpLeG7m8ah4bq1WSjDquG7neG7neG7leG7m0AvL+G6tcOiw6zhur/DreG6vSThu6fhur/huqfhu53DrDLDreG7lWnhu6Phu5sk4bunw6wv4budIns8L+G7o+G7lWnhu4syw6LhuqfDoi/hurPhu4to4bud4budZy97PHs+XzwgX3swL+G7neG7ncaw4bunw6xfaMOqMsOs4bq9X+G7ncOq4bqnX+G6teG7i+G7p+G6v8OiPjEkZ+G7leG6vSgpLzpJ4bq/ZeG7oynhu5XDqjPhu5Up4bql4bq/xJHhu6Mp4budxqHhu4MpaMOqM8Os4bq9KeG7ncOqw6kp4bua4buL4budxqHhu4vhu6fhur/DrTLhurMp4bq1w6rhu4sp4bqzZcOsw6opw6zDquG6o8OsKeG6tOG7iuG7puG6vsOCLT4xPSnDouG7iynhurRtw6zhur0p4bud4bupKcOic+G7keG6tSnhurxpMsaw4buL4buaw63hur/hu53Dqkhp4bq/w6zhuqcpKnfDrMOqJinhu6c0KeG6tG3DrOG6vSnhu53hu6kp4bum4bq/xqEp4bqy4bq/4buL4bud4bqn4bq1w6rDrOG7i2nhu4vhur3hu6kpKsONdiYp4bubNsOsKcaw4bujw6Phu50kKSrhu7PDrMOqQCnhu5zDquG6pynDjDLhu53hur/hu4vDrDJpL+G7nOG7nMav4bumw4wmPy/hu5U6P+G7lSnhurVpMuG7m+G7m1ko4buV4bqy4buLw6Lhu6koOuG7nMOq4bqn4buLKeG6puG7oj0p4budw6rhu6Nu4bq1KeG7muG7i+G7ncah4buL4bun4bq/w60y4bqzPSnDouG7iynhurxpMsaw4buL4buaw63hur/hu53Dqkhp4bq/w6zhuqcp4buVw6pu4bq/KcOq4buR4buVKeG7p8O14bq/KeG6tW3DrOG6vSnhu53hu6kp4bq1bcOs4bq9KcOs4bq9w6plKeG7m+G6v8Osw6opw6pq4bq1KeG7puG6v8ahKeG6suG6v+G7i+G7neG6p+G6tcOqw6zhu4tp4buL4bq94bupKeG6tXEyKcONdinDrOG6vcOq4bq/Y8OsKeG6tXThu6Mp4bunNCnhu5XDqjPhu50p4budxqHhur/DqcOsPSnhurXhu4kp4budw6rDqSnhu5vDuSnDonDDrOG6vSnhuqXDqSnhuqXhur/EkeG7oynhu53GoeG7gynhurNlw6zDqinDrMOq4bqjw6wp4bq04buK4bum4bq+w4ItPjEp4bq14buJKeG7ncah4bq/ZeG7oynhurXDqnTDrOG6vSnDrMOq4bqpPSlow6ptw6zhur0p4bq1xIPDrCnhu53DquG7kynhu4vGsOG7qT0pw6zDqnPDrOG6vSnhurXhu4kpw6zhur3hu6Phu6kp4bq14buPKcOi4bq/4bq5w6wp4bqz4bq/ZMOsKeG6s2XDrMOqKcOsw6HDrOG6vSnDquG7j8OsJD8v4buVOj/hu5Up4bq1aTLhu5vhu5tZKOG7leG6suG7i8Oi4bupKDrDiuG6v2XDrCnhurThu48p4buX4bujMsOsKeG7luG7ozbDrClp4burKcOic+G7keG6tSnhu5XDquG6scOtKeG6tcOq4bqj4bujKeG6ouG7oykq4bqmw413JinhuqUyw6zhur0p4bud4bq/ZMOsKcOqNMOsw6op4bqlM8Osw6op4bq94bq/Mynhu53hu4HDrMOqKcOq4bq/ZeG7oynhu5fhu6M2KeG6tXEyKWnhu4s14bq/KeG7ncOq4bujbuG6tSnDrDThu6kkPy/hu5U6P+G7lSnhurVpMuG7m+G7m1ko4buV4bqy4buLw6Lhu6koOuG7nMahc8O14bq1KeG6peG7iT0pw412KeG6tXLDrOG6vSnhuqU3KeG6tcOj4buVKeG7lcOq4bqt4buVKeG7m8O5KcOicMOs4bq9KWjDquG6scOsKeG6tcOj4buVKeG7ncOq4bujbuG6tSnhu5rhu4vhu53GoeG7i+G7p+G6v8OtMuG6synhuqXDqSnhuqXhur/EkeG7oynhu53GoeG7gynhurNlw6zDqinDrMOq4bqjw6wp4bq04buK4bum4bq+w4ItPjEp4buTKeG7ncOqw6kpw6zDquG6qSnhuqVkw6wp4budxqHhu6PDrOG6vSnhurPhu4fDrMOqKeG7pzQp4bq14buJKcOs4bq94buj4bupKeG6teG7jynhurXDquG7o+G7qcOpw6wp4bqz4bq/ZMOsKcOsw6HDrOG6vSnDquG7j8OsJD8v4buVOj/hu5Up4bq1aTLhu5vhu5tZKOG7leG6suG7i8Oi4bupKDrhu5zDqmsyKeG7ncOq4buj4bqvw6wp4budxqFjw6wp4bqlc+G7keG6tSk+Ii97ICnhu5fhu6Nu4bq1KeG6veG6vzIp4budw6o0w6zDqinhu6fhur9jw6wp4bqm4buiKXHDrOG6vSnDqsOzPSnDrMOq4bulw6zhur0pw6xzw7XhurUp4bq1w6rhu4Up4bq14buJKeG7ncOqw6kpw63hu6MyKeG7ncOq4bujbuG6tSnhu5rhu4vhu53GoeG7i+G7p+G6v8OtMuG6synhu5sy4bujKWjDquG6vynhuqVz4buR4bq1KeG6psONdynDquG7i8Oh4bq1KeG6teG7jynhu5fhu6Myw6wp4buX4bujNsOsKWnhu6spw6Jz4buR4bq1KeG7lcOq4bqxw60p4buX4bujbuG6tSnhur3hur8yKeG6tcOq4buLKeG7lcOq4bqt4buVKWlz4bujKcOqNMOsw6okKeG6vOG6vzMp4budxqHhu4Mpw6rhu5Hhu5Up4bqlb8Os4bq9KcOq4bq/ZcOsKeG6tcOqczIp4bqlc+G7keG6tSnhu53Dqm3DrOG6vSnhurMz4buLJD8v4buVOj/hu5Up4bq1aTLhu5vhu5tZKOG7leG6suG7i8Oi4bupKDrhu5zGoXPDteG6tSnhuqXhu4k9KeG7ncOqM8Os4bq9KVsp4bundTIp4buX4bujMj0p4bqm4buiKeG6tXLDrOG6vSnhuqU3KWjhu6spw63Ds+G7nSnhu53DqmsyKeG7ncOq4buj4bqvw6wp4budc+G7j8Os4bq9KeG7ncO6KeG7p8O14bq/KeG6tW3DrOG6vSnhu53hu6kpw6Jz4buR4bq1KeG7lcOq4bqxw60pxqDhu4vhurXDquG6pynhurVxMinhu5zDqnDhu6kp4buaZinhu6fEkSnhu6fhur9l4bq1KeG6pcOh4budKcOt4bujMildXSQ8PDwpaeG6v8SR4bujKeG7ncOq4bujbuG6tSnhuqXhur/EkeG7oynhu53GoeG7gynhurNlw6zDqinDrMOq4bqjw6wp4bq04buK4bum4bq+w4ItPjEp4bqzYcOs4bq9KWjDqjPDrOG6vSnhu53DqsOpKeG6peG7j8OsKcOixKnDrOG6vSnhu53hur/EkcOtKcOsOMOs4bq9KcOi4buLKcOqN8Os4bq9KcOsNOG7qSnhu5XDqm7hur8pw6rhu5Hhu5Up4bunw7Xhur8p4bq1bcOs4bq9KeG7neG7qSnDonPhu5HhurUp4buVw6rhurHDrSnGoOG6p+G6veG6p8Os4bqnxqHhu4vDrCnhurVxMinDjXYp4buVw6oz4budKeG7ncah4bq/w6nDrCQ/L+G7lTo/4buVKeG6tWky4bub4bubWSjhu5XhurLhu4vDouG7qSg64bqkZMOsKcOsMuG7qT0pw6zhur3hu4s04bq/KWnhur9l4bujKeG7lcOqM+G7lSnhuqXhur/EkeG7oynhu53GoeG7gynhurNhw6zhur0paMOqM8Os4bq9KeG7ncOqw6kp4bql4buPw6wpw6LEqcOs4bq9PSnhuqbhu6Ip4bq1w6rhu4Up4bubw7kpw6Jww6zhur0pw6Lhu6Phu6kpw6zDqsOj4budKcOtw7Phu50paeG7izXhur8p4budw6rhu6Nu4bq1KeG6tcOqbsOs4bq9KeG6tOG7iuG7puG6vsOCLT4xKeG6pTcpw63hu6MyKWk0Kcag4bqnw63DouG6p+G7m+G6v+G7p+G6v8ahKeG6tXEyKcOqN8Os4bq9KeG6vOG6v2nhuqcyw6I9KcOtw7Phu50paeG7izXhur8p4budw6rhu6Nu4bq1KWjDqjPDrOG6vSnhu6fhur/GoeG7o+G7myQ/L+G7lTo/4buVKeG6tWky4bub4bubWSjhu5XhurLhu4vDouG7qSg6w4w4w60pw6zhur3hu4sz4bq/PSnhuqbhu6Ip4bqlNynhuqXDoeG7nSnDreG7ozIpXTw8JDw8PClp4bq/ZeG7oynhu53GoeG7h8Osw6op4budw6rhu6Nu4bq1Kcag4bqnw63DouG6p+G7m+G6v+G7p+G6v8ahKeG7mzLhu6MpaMOq4bq/KeG6tcOj4buVKeG7lcOq4bqt4buVKeG7m8O5KcOicMOs4bq9KWnhu4s14bq/KeG7ncOq4bujbuG6tSnDrDThu6kkLyQ/L+G7lTo/4buVKeG6tWky4bub4bubWSjhu5V34buj4budw6rhu4vGoSg6KuG7nOG7nMav4bumw4wv4bum4bq/4bqn4budw6wyw60rJj8v4buVOg==

Bình luận

Xin vui lòng gõ tiếng Việt có dấu

Tin cùng chuyên mục

Seoul thúc đẩy đối thoại liên Triều, nhưng không dùng tập trận chung Mỹ - Hàn làm con bài thương lượng

Seoul thúc đẩy đối thoại liên Triều, nhưng không dùng tập trận chung Mỹ - Hàn làm con bài thương lượng

Thế giới
(Baothanhhoa.vn) - Ngày 7/12, Cố vấn An ninh Quốc gia Hàn Quốc Wi Sung-lac tuyên bố, Seoul đang nỗ lực thúc đẩy nối lại đối thoại với Bình Nhưỡng nhằm khởi động tiến trình cùng tồn tại trên bán đảo Triều Tiên. Tuy nhiên, trong bối cảnh tranh cãi về việc có nên thay...
Chứng nhận tín nhiệm mạng
Việt Long Phần mềm tòa soạn
hội tụ thông minh